Why is Indoco Remedies falling/rising?

As of 19-Sep, Indoco Remedies Ltd is currently priced at 300.95, reflecting a decrease of 1.05 or 0.35%. The stock has underperformed its sector by 0.62% today, despite reaching an intraday high of Rs 311.75, which represents a 3.23% increase at its peak. Over the past week, the stock has shown a modest gain of 0.72%, but its year-to-date performance is concerning, with a decline of 9.49%. The company has faced significant challenges, including a drastic fall in operating profit by 29.36%, leading to negative results for 11 consecutive quarters. Additionally, the stock's return over the past year is down by 19.59%, while profits have plummeted by 263.6%, indicating a troubling trend that has likely contributed to the recent price decline.
In the broader market context, the Sensex has outperformed Indoco Remedies, gaining 0.88% over the past week and 5.74% year-to-date. This underperformance against the benchmark is compounded by a significant drop in investor participation, with delivery volume falling by 70.4% compared to the 5-day average. The stock's liquidity remains adequate for trading, but the high institutional holdings of 20.18% suggest that these investors are wary of the company's poor long-term growth prospects, as reflected in the negative operating profits and consistent underperformance against the BSE500 over the last three years.